Korean J Gastroenterol.  2011 Dec;58(6):297-299. 10.4166/kjg.2011.58.6.297.

How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?

• Park KS

• KMID: 1043327
• DOI: http://doi.org/10.4166/kjg.2011.58.6.297

Abstract

No abstract available.

MeSH Terms

Gastrointestinal Diseases/*economics
*Health Care Costs
Humans

Reference

References

1. World Health Organization. Constitution of the World Health Organization-Basic Documents. 45th ed. (Suppl).Geneva: WHO;October 2006.

2. Lewis DM. WHO definition of health remains fit for purpose. BMJ. 2011; 343:d5357.

3. Lewens T, McMillan J. Defining disease. Lancet. 2004; 363:664.

4. Cortez-Pinto H, Gouveia M, dos Santos Pinheiro L, Costa J, Borges M, Vaz Carneiro A. The burden of disease and the cost of illness attributable to alcohol drinking–results of a national study. Alcohol Clin Exp Res. 2010; 34:1442–1449.

5. Rosen AK, Reid R, Broemeling AM, Rakovski CC. Applying a risk-adjustment framework to primary care: can we improve on existing measures? Ann Fam Med. 2003; 1:44–51.

6. Massey RU, Rosen AK, Loveland S, et al. Cost of care or burden of disease? Applying diagnostic cost groups to examine the disease burden of VA facilities: comparing the six "Evaluating VA Costs" study sites with other VA sites and medicare. The burden of disease and the cost of illness attributable to alcohol drinking–results of a national study. Conn Med. 1978; 42:263.

7. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics. 2011; 29:863–874.

8. Gaunt ER, Harvala H, McIntyre C, Templeton KE, Simmonds P. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol. 2011; 52:215–221.

9. Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm. 2008; 14:352–362.

10. Chou LF. Estimating medical costs of gastroenterological diseases. World J Gastroenterol. 2004; 10:273–278.

11. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002; 122:1500–1511.

12. Kim CY, Park HW, Ko SK, et al. The financial burden of asthma: a nationwide comprehensive survey conducted in the republic of Korea. Allergy Asthma Immunol Res. 2011; 3:34–38.

13. Park JI. Health economic approach on mental health in Korea. J Korean Neuropsychiatr Assoc. 2010; 49:149–156.

14. Lim JH, Kim HS, Hyung HO, et al. A study on the quality of life and the economic burden of Korean patients with viral warts. Korean J Dermatol. 2010; 48:33–38.

15. Lim SJ, Kim HJ, Nam CM, et al. Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health. 2009; 42:251–260.

16. Kim KH, Kim JW, Rhee JY, et al. Cost analysis of iron-related complications in a single institute. Korean J Intern Med. 2009; 24:33–36.

17. Kim J, Hahm MI, Park EC, et al. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health. 2009; 42:190–198.

18. Yang BM, Bae EY, Kim J. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance. Health Aff (Millwood). 2008; 27:179–187.

19. Suh GH, Jung HY, Lee CU, Choi S. Korean Galantamine Study Group. Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study. J Korean Med Sci. 2008; 23:10–17.

20. Lee Y, Kim H, Cho I. Factors influencing care burdens of care-givers of elders with dementia who request dementia domicil-iary welfare services. J Korean Acad Fundam Nurs. 2008; 15:274–283.

21. Lee TJ. Use of economic evaluation in the listing and pricing of pharmaceuticals. J Prev Med Public Health. 2008; 41:69–73.

22. Lang HC, Wu JC, Yen SH, Lan CF, Wu SL. The lifetime cost of hepatocellular carcinoma: a claims data analysis from a medical centre in Taiwan. Appl Health Econ Health Policy. 2008; 6:55–65.

23. Kang HY, Kang DR, Jang YH, et al. Estimating the economic burden of osteoporotic vertebral fracture among elderly Korean women. J Prev Med Public Health. 2008; 41:287–294.

24. Hwang JA, Park TC, Jung SH, et al. Direct medical costs of type 2 diabetic patients in the tertiary hospital. Korean Diabetes J. 2008; 32:259–268.

25. Chang SM, Cho SJ, Jeon HJ, et al. Economic burden of schizophrenia in South Korea. J Korean Med Sci. 2008; 23:167–175.

26. Park CS, Kang HY, Kwon I, Kang DR, Jung HY. Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database. J Prev Med Public Health. 2006; 39:397–403.

27. Jung HK, Jang BH, Kim YH, et al. Health care costs of digestive diseases in Korea. Korean J Gastroenterol. 2011; 58:323–331.

28. Kim NY, Kim JW, Kim HJ, et al. Distribution of upper gastroduodenal diseases in health check-up subjects in 2006. Korean J Helicobacter Up Gastrointest Res. 2008; 8:1–8.